Cargando…
Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine
We reviewed clinical evidence for the use of ivabradine in systolic heart failure (HF), in which it appears to improve symptoms, improve quality of life, prevent hospitalization, and prolong survival, thereby addressing unmet needs in the management of HF. Ivabradine provides symptomatic benefits in...
Autor principal: | Pereira-Barretto, Antonio Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819545/ https://www.ncbi.nlm.nih.gov/pubmed/26817946 http://dx.doi.org/10.1007/s40256-016-0159-2 |
Ejemplares similares
-
Advances in the management of heart failure: the role of ivabradine
por: Müller-Werdan, Ursula, et al.
Publicado: (2016) -
Ivabradine in the treatment of systolic heart failure - A systematic review and meta-analysis
por: Anantha Narayanan, Mahesh, et al.
Publicado: (2017) -
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
por: Borer, Jeffrey S., et al.
Publicado: (2012) -
Heart Failure with Preserved Ejection Fraction: the Major Unmet Need in Cardiology
por: Shim, Chi Young
Publicado: (2020) -
Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2022)